Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 2—February 2009

Research

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007

Andrew C. SteerComments to Author , Adam Jenney, Joseph Kado, Michael F. Good, Michael Batzloff, Lepani Waqatakirewa, E. Kim Mullholland, and Jonathan R. Carapetis
Author affiliations: University of Melbourne, Melbourne, Victoria, Australia (A.C. Steer, A. Jenney, E.K. Mullholland, J.R. Carapetis); Ministry of Health, Suva, Fiji (J. Kado, L. Waqatakirewa); Queensland Institute of Medical Research, Brisbane, Queensland, Australia (M.F. Good, M. Batzloff); London School of Hygiene and Tropical Medicine, London, UK (E.K. Mullholand); Menzies School of Health Research, Casuarina, Northern Territory, Australia (J.R. Carapetis)

Main Article

Table 3

Underlying coexisting medical conditions in patients with invasive GAS disease, Fiji, 2005–2007

Condition No. (%) patients
Diabetes 25 (42)
Renal disease 13 (22)
Cardiac disease 13 (22)
Malignancy 5 (8)
Immunosuppression 2 (3)
Lung disease 3 (5)
Liver disease
 1 (2)
Any coexisting condition 38 (63)
Only 1 coexisting condition 21 (35)
2 coexisting conditions† 11 (18)
>2 coexisting condition† 6 (10)

*GAS, group A streptococci.
†Nine patients had diabetes and renal disease.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO